Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome

Diabetes-associated chronic kidney disease is a pandemic issue. Despite the global increase in the number of individuals with this chronic condition together with increasing morbidity and mortality, there are currently only limited therapeutic options to slow disease progression. One of the reasons...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecamwasam, Ashani, Ekinci, Elif I., Saffery, Richard, Dwyer, Karen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555227/
https://www.ncbi.nlm.nih.gov/pubmed/32927866
http://dx.doi.org/10.3390/biomedicines8090341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555227/
https://www.ncbi.nlm.nih.gov/pubmed/32927866
http://dx.doi.org/10.3390/biomedicines8090341

Ejemplares similares